• 1. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
• 2. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?
  Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890
• 3. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
• 4. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 5. Emulsion soft templating of carbide-derived carbon nanospheres with controllable porosity for capacitive electrochemical energy storage?
  M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990

• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenol ethers Anisoles

5-Bromo-2-chloro-4-((4-methoxybenzyl)oxy)pyrimidine: A Comprehensive Overview

The compound 5-Bromo-2-chloro-4-((4-methoxybenzyl)oxy)pyrimidine, with CAS No. 1188329-59-0, is a highly specialized pyrimidine derivative that has garnered significant attention in the fields of medicinal chemistry and pharmacology. Pyrimidines, as a class of heterocyclic compounds, have long been recognized for their versatile applications in drug discovery, particularly in the development of antiviral agents, anticancer drugs, and modulators of various cellular pathways. The unique substitution pattern of this compound—featuring bromine at position 5, chlorine at position 2, and a (4-methoxybenzyl)oxy group at position 4—confers it with distinct chemical and biological properties that make it a valuable tool in modern drug design.

Recent advancements in synthetic chemistry have enabled the efficient synthesis of 5-Bromo-2-chloro-4-((4-methoxybenzyl)oxy)pyrimidine, leveraging both traditional multi-step syntheses and innovative one-pot methodologies. Researchers have employed various strategies, including nucleophilic aromatic substitution and transition-metal-catalyzed coupling reactions, to construct this complex molecule. These methods not only enhance the scalability of production but also pave the way for further structural modifications to explore its pharmacological potential.

The biological activity of 5-Bromo-2-chloro-4-((4-methoxybenzyl)oxy)pyrimidine has been extensively studied in recent years. Preclinical studies have demonstrated its potent inhibitory effects on key enzymes involved in viral replication, making it a promising candidate for antiviral therapy. Additionally, this compound has shown selective cytotoxicity against various cancer cell lines, suggesting its potential role in oncology. The presence of the (4-methoxybenzyl)oxy group at position 4 is believed to play a critical role in modulating its bioavailability and pharmacokinetic properties, thereby enhancing its therapeutic index.

In terms of structural elucidation, modern analytical techniques such as high-resolution mass spectrometry (HRMS), nuclear magnetic resonance (NMR), and X-ray crystallography have been instrumental in confirming the molecular structure of 5-Bromo-2-chloro-4-((4-methoxybenzyl)oxy)pyrimidine. These studies have provided insights into its conformational flexibility and stereochemical integrity, which are crucial for understanding its interactions with biological targets.

The integration of computational chemistry tools has further augmented our understanding of this compound's behavior at the molecular level. Molecular docking studies have revealed that 5-Bromo-2-chloro-4-((4-methoxybenzyl)oxy)pyrimidine exhibits favorable binding affinities towards several protein targets, including kinases and proteases. These findings underscore its potential as a lead compound for drug development programs targeting diverse therapeutic areas.

From an environmental perspective, the synthesis and application of 5-Bromo-2-chloro-4-((4-methoxybenzyl)oxy)pyrimidine align with green chemistry principles. Researchers have increasingly adopted eco-friendly reaction conditions to minimize waste generation and reduce the ecological footprint associated with its production. This shift reflects a broader trend towards sustainable practices in the chemical industry.

In conclusion, 5-Bromo-2-chloro-4-((4-methoxybenzyl)oxy)pyrimidine stands as a testament to the rapid progress being made in medicinal chemistry. Its unique structure, coupled with cutting-edge research methodologies, positions it as a valuable asset in the quest for novel therapeutic agents. As ongoing studies continue to unravel its full potential, this compound is poised to make significant contributions to the field of drug discovery.

• 358789-15-8(5-Bromo-2-chloro-4-(4-methoxyphenoxy)pyrimidine)
• 1325694-78-7(5-bromo-4-chloro-6-((4-methoxybenzyl)oxy)pyrimidine)
• 937793-24-3(2-[[(5-Bromo-2-chloro-4-pyrimidinyl)oxy]methyl]Benzonitrile)
• 480998-38-7(Pyrimidine, 2-chloro-4-[(4-methoxyphenyl)methoxy]-)
• 664988-37-8(PYRIMIDINE, 5-BROMO-2,4-BIS[(4-METHOXYPHENYL)METHOXY]-)
• 108381-28-8(4-(Benzyloxy)-2-chloropyrimidine)
• 205672-19-1(4-(Benzyloxy)-5-bromo-2-chloropyrimidine)
• 627784-09-2(QUINAZOLINE, 6-BROMO-2-CHLORO-4-[[4-(PHENYLMETHOXY)PHENYL]METHOXY]-)
• 1229186-65-5(5-Bromo-2-chloro-4-(3-methoxyphenoxy)pyrimidine)
• 1289005-72-6(5-bromo-2-chloro-4-ethoxypyrimidine)